Skip to content

Use of Tablet Neuroten Dm in the patients of Peripheral Diabetic Neuropathy

A Clinical Study OF Neuroten DM Kalpita Yoga In The Management Of Madhumehjanya Updrava Peripheral Diabetic Neuropathy - nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071922
Enrollment
40
Registered
2024-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere

Interventions

None listed

Sponsors

Post Graduate Institute Of Ayurved Jodhpur,Rajastan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having cardinal symptoms of Madhumeha Upadrava like Daha, Harsha, Suptata will be selected 2 Diagnosed cases of Diabetic Neuropathy will be included 3 Mild to moderate Neuropathy patients having Toronto score between 6 to 11 will be included 4 Both fresh and treated cases will be included in the study 5 On-going oral hypoglycaemic agents will be continued during the study 6 No other neuropathy-managing drugs are allowed during the study period 7 Patients aged between 30 to 70 years will be included of both sexes 8 Patients who are willing to sign written consent will be included 9 Patient should be capable of obeying Pathya–apathya

Exclusion criteria

Exclusion criteria: 1 IDDM (Type 1 DM) will be excluded from study 2 Patient with any other serious condition or disease which impact nerves except Diabetic Peripheral Neuropathy will be excluded 3 Pregnant and lactating women will be excluded 4 Patients having any other associated clinical condition like Dementia, Parkinson, or Stroke which influence peripheral nerve function will be excluded 5 Patient having ulceration/infection of feet 6 Medical/Surgical condition limiting functional mobility 7 Non-ambulatory patients 8 who are not willing to participate / consent

Design outcomes

Primary

MeasureTime frame
change in the subjective parametersTimepoint: 60 days

Secondary

MeasureTime frame
change in the objective parametersTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Pramod Kumar Mishra

Post Graduate Institute Of Ayurved Jodhpur,Rajastan

simmidiwan05@gmail.com8160359483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026